464 related articles for article (PubMed ID: 8938155)
21. [Recurrence of virus B hepatitis after liver transplantation].
Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
[TBL] [Abstract][Full Text] [Related]
22. Liver graft infection by HBV S-gene mutants in transplant patients receiving long-term HBIg prophylaxis.
Santantonio T; Gunther S; Sterneck M; Rendina M; Messner M; Launois B; Francavilla A; Pastore G; Will H
Hepatogastroenterology; 1999; 46(27):1848-54. PubMed ID: 10430358
[TBL] [Abstract][Full Text] [Related]
23. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
24. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.
Roche B; Feray C; Gigou M; Roque-Afonso AM; Arulnaden JL; Delvart V; Dussaix E; Guettier C; Bismuth H; Samuel D
Hepatology; 2003 Jul; 38(1):86-95. PubMed ID: 12829990
[TBL] [Abstract][Full Text] [Related]
25. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
[TBL] [Abstract][Full Text] [Related]
26. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
27. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
28. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
29. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
30. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
[TBL] [Abstract][Full Text] [Related]
31. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
32. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
[TBL] [Abstract][Full Text] [Related]
33. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
[TBL] [Abstract][Full Text] [Related]
34. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
Ilan Y; Eid A; Tur-Kaspa R
Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
[TBL] [Abstract][Full Text] [Related]
35. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
[TBL] [Abstract][Full Text] [Related]
36. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
37. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.
Di Paolo D; Lenci I; Cerocchi C; Tariciotti L; Monaco A; Brega A; Lotti L; Tisone G; Angelico M
Transpl Int; 2010 Nov; 23(11):1105-12. PubMed ID: 20492620
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Naoumov NV; Lopes AR; Burra P; Caccamo L; Iemmolo RM; de Man RA; Bassendine M; O'Grady JG; Portmann BC; Anschuetz G; Barrett CA; Williams R; Atkins M
J Hepatol; 2001 Jun; 34(6):888-94. PubMed ID: 11451173
[TBL] [Abstract][Full Text] [Related]
39. HBIG efficacy in preventing HBV infection in infants.
D'Elia R; Pornaro E; Gussetti N; Largajolli G
Dev Biol Stand; 1983; 54():377-81. PubMed ID: 6653892
[TBL] [Abstract][Full Text] [Related]
40. Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
Hooman N; Rifai K; Hadem J; Vaske B; Philipp G; Priess A; Klempnauer J; Tillmann HL; Manns MP; Rosenau J
Liver Transpl; 2008 Apr; 14(4):435-42. PubMed ID: 18383078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
